Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT01112436
Other study ID # ChunaAngUH
Secondary ID
Status Recruiting
Phase Phase 4
First received April 22, 2010
Last updated June 23, 2011
Start date May 2010
Est. completion date April 2012

Study information

Verified date April 2010
Source Chung-Ang University Hospital
Contact n/a
Is FDA regulated No
Health authority Korea: Institutional Review Board
Study type Interventional

Clinical Trial Summary

This prospective randomized study aims to evaluate the effectiveness of periarticular multi-drug regimen injection on the relief of pain in patients undergoing partial hip replacement.

Total 258 patients will be randomized into one of two groups (groupC or groupI) based on Excel number generation.

Patients in group C will receive no medication intraoperatively, and patients in group I will receive oral oxycodone and celecoxib preoperatively and a periarticular injection of multi-drug regimen during operation.

Visual analogue scale pain scores, fentanyl consumption and the frequency at which patients pushed the button (FPB) of a patient-controlled analgesia system will be recorded at 1, 4, 7 postoperative day.


Description:

Patients in group I will receive oxycodone SR 10 mg, and celecoxib 200 mg with 10 ml of water 1 hour before surgery.

And patients in group I will receive periarticular injection of 50 ml solution which contains ropivacaine 15 mg, epinephrine 0.3 mg, cefmetazole 1000mg, ketorolac 30 mg and morphine HCL 10mg before closure of surgical wound.

Patients in group C will receive no medication.


Recruitment information / eligibility

Status Recruiting
Enrollment 258
Est. completion date April 2012
Est. primary completion date April 2012
Accepts healthy volunteers No
Gender Both
Age group N/A and older
Eligibility Inclusion Criteria:

- femoral neck fracture

- partial hip replacement

Exclusion Criteria:

- r/o infection

- reoperation

- mental change

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Drug:
periarticular injection of multidrug regimen
periarticular injection of combination of ropivacaine 15 mg, epinephrine 0.3mg, cefmetazole 1000mg, ketorolac 30mg, morphine HCL 10 mg
none of medication preoperatively and intraoperatively
Patients in Group C wil receive none of medication preoperatively and intraoperatively

Locations

Country Name City State
Korea, Republic of ChungAng University Seoul

Sponsors (1)

Lead Sponsor Collaborator
Chung-Ang University Hospital

Country where clinical trial is conducted

Korea, Republic of, 

Outcome

Type Measure Description Time frame Safety issue
Primary Visual analogue scale 1day Patients will be assessed for pain using a visual analogue pain scale (VAS). It is usually a horizontal line, 100 mm in length, anchored by word descriptors at each end; left side end which represents 0 is 'No pain', right side end with 100 is 'Very severe pain'. The patient marks on the line the point that they feel represents their perception of their current state. The VAS score is determined by measuring in millimeters from the left hand end of the line to the point that the patient marks.
To check the severity of pain VAS will be measured at post op 1day.
Post Op 1 day No
Secondary Opioid consumption 1day The patients will be taught to push the button of the PCA system, which delivered a bolus of drug, each time pain occurred. In the case of persistent pain greater than a visual analogue scale (VAS) pain score of 30 mm, an additional 50 µg of fentanyl will be injected intra-venously by nursing staff until the pain was relieved to a level less than a VAS pain score of 30 mm. And sum of delivery from PCA system and additional opioid fom immediately after operation to post op 1daywill be measured. Post Op 1 day No
Secondary FPB 1day The patients will be taught to push the button of the PCA system, which delivered a bolus of drug, each time pain occurred. And total frequency of patient to push the button of the PCA machine (FPB) fom immediately after operation to post op 1day will be measured. Post Op 1 day No
Secondary delirium rating scale at admission Delirium rating scale wiil be measured to compare with the post op delerium scale at admisssion. at admission No
Secondary Visual Analogue Scale 4day Patients will be assessed for pain using a visual analogue pain scale (VAS). It is usually a horizontal line, 100 mm in length, anchored by word descriptors at each end; left side end which represents 0 is 'No pain', right side end with 100 is 'Very severe pain'. The patient marks on the line the point that they feel represents their perception of their current state. The VAS score is determined by measuring in millimeters from the left hand end of the line to the point that the patient marks.
To check the severity of pain VAS will be measured at post op 4day.
Post OP 4day No
Secondary Visual Analogue Scale 7day Patients will be assessed for pain using a visual analogue pain scale (VAS). It is usually a horizontal line, 100 mm in length, anchored by word descriptors at each end; left side end which represents 0 is 'No pain', right side end with 100 is 'Very severe pain'. The patient marks on the line the point that they feel represents their perception of their current state. The VAS score is determined by measuring in millimeters from the left hand end of the line to the point that the patient marks.
To check the severity of pain VAS will be measured at post op 7day.
Post Op 7day No
Secondary Opioid consumption 4day The patients will be taught to push the button of the PCA system, which delivered a bolus of drug, each time pain occurred. In the case of persistent pain greater than a visual analogue scale (VAS) pain score of 30 mm, an additional 50 µg of fentanyl will be injected intra-venously by nursing staff until the pain was relieved to a level less than a VAS pain score of 30 mm. And sum of delivery from PCA system and additional opioid fom post op 1day to post op 4 day will be measured. Post Op 4 day No
Secondary Opioid consumption 7day The patients will be taught to push the button of the PCA system, which delivered a bolus of drug, each time pain occurred. In the case of persistent pain greater than a visual analogue scale (VAS) pain score of 30 mm, an additional 50 µg of fentanyl will be injected intra-venously by nursing staff until the pain was relieved to a level less than a VAS pain score of 30 mm. And sum of delivery from PCA system and additional opioid fom post op 4day to post op 7 day will be measured. Post Op 7 day No
Secondary FPB 4day The patients will be taught to push the button of the PCA system, which delivered a bolus of drug, each time pain occurred. And total frequency of patient to push the button of the PCA machine (FPB) fom post op 1day to post op 4 day will be measured. Post Op 4 day No
Secondary FPB 7day The patients will be taught to push the button of the PCA system, which delivered a bolus of drug, each time pain occurred. And frequency of patient to push the button of the PCA machine (FPB) fom post op 4day to post op 7day will be measured. Post Op 7 day No
Secondary delirium rating scale 1day Delirium rating scale wiil be measured to check the incidence and severity of delirium at post-op 1day. Post Op 1day No
Secondary delirium rating scale 4day Delirium rating scale wiil be measured to check the incidence and severity of delirium at post-op 4day. Post Op 4day No
Secondary delirium rating scale 7day Delirium rating scale wiil be measured to check the incidence and severity of delirium at post-op 7day. Post Op 7day No
See also
  Status Clinical Trial Phase
Completed NCT02422355 - A Focused Registry on the Femoral Neck System (FNS) in Patients With Femoral Neck Fractures
Withdrawn NCT02202122 - Interest of the OSA (Obstructive Sleep Apnea) Predictive Scores in the Prognosis of Postoperative Mortality of Femoral Neck Fractures N/A
Terminated NCT01219062 - Postoperative Pain Control After Hip Hemiarthroplasty: Intrathecal Morphine vs Periarticular Infiltration of Bupivacaine Phase 4
Active, not recruiting NCT02362971 - External Validity of a Randomized Trial in Patients With a Femoral Neck Fracture N/A
Completed NCT02591342 - Comparison of a Cemented, Polished Tapered Stem and an Anatomic Stem for Femoral Neck Fracture N/A
Recruiting NCT05171140 - Influence of the Spatial Distribution of Hollow Screws on the Blood Supply and Prognosis of Femoral Neck Fractures N/A
Completed NCT02433548 - Fascia Iliaca Block in the Emergency Department for Analgesia After Femoral Neck Fracture Phase 4
Active, not recruiting NCT03357445 - AVANTAGE® RELOAD Double Mobility Acetabular Cup -Clinical Study N/A
Recruiting NCT03550079 - Fixation for the Treatment of Femoral Neck Fractures N/A
Completed NCT04879472 - Early Functional Outcome of Operative Treatment of Displaced Femoral Neck Fractures in Two Kenyan Orthopaedic Centres
Completed NCT00913679 - A Comparison of Two Different Surgical Techniques in Hip Resurfacing Arthroplasty N/A
Recruiting NCT02877472 - Porous Tantalum Rods Improve the Hip Joint Function of Patients With Avascular Necrosis of the Femoral Head N/A
Completed NCT01052974 - Perioperative Analgesia by Femoral Perineural Catheter for Femoral Neck Fracture - Study KTcol Phase 4
Terminated NCT02030431 - Dynaloc for Treatment of Femoral Neck Fractures N/A
Completed NCT01114646 - Functional Status, Morbidity and Mortality in Cemented Versus Press-Fit Hemiarthroplasty N/A
Completed NCT02512094 - Validity and Reliability of Thai Version of Barthel Index for Hip Fracture Patients N/A
Recruiting NCT02148848 - Short-term Functional Recovery Between Early- and Late Bisphosphonate Treatment Following Hemiarthroplasty Phase 4
Completed NCT01644227 - Dual Mobility Cup in Total Hip Arthroplasty Preventing Dislocation in Patients at Risk N/A
Active, not recruiting NCT02901938 - Feasibility of Implantation of Cemented Femoral Stem for Osteoporotic Femoral Neck Fracture in Elderly Patients N/A
Completed NCT02771639 - Early Periprosthetic Joint Infection and Outcome Debridement, Antibiotics and Implant Retention N/A